Search results
Author(s):
Leah M Raj
,
Leslie A Saxon
Added:
3 years ago
This study reviews how haemodynamic monitoring devices that provide indirect or direct measures of heart failure status relate to cardiac rhythm management devices for the management of patients with the condition. The role of patient-facing software and services that provide information from these devices to patients can create a new model of heart failure disease management. In this care…
View more
Cecilia Linde
Job title: Professor and Head of Cardiology
Author
Author(s):
Daniele Muser
,
Simon A Castro
,
Jackson J Liang
,
et al
Added:
3 years ago
The role of catheter ablation (CA) in the management of ventricular tachycardia (VT) is becoming increasingly relevant, having repeatedly shown its superiority to medical therapy in reducing the arrhythmic burden, thus improving prognosis and quality of life in patients with structural heart disease presenting with VT.1–4 In such patients, recurrent VT and heart failure (HF) status are connected…
View more
Author(s):
Niraj Varma
,
Renato Pietro Ricci
,
Loredana Morichelli
Added:
3 years ago
Monitoring after implant of patients with cardiac implantable electronic devices (CIED) forms a part of both device and patient care, and is the responsibility of the implanting centre. Monitoring is challenged by the increasing number and technical complexity of implanted devices coupled with the increasing clinical complexity of the patient population. Current practice is based on quarterly to…
View more
Heart Failure Remote Monitoring
Author(s):
Joanne K Taylor
,
Fozia Ahmed
Added:
11 months ago
Article
Author(s):
Matthew McKillop
Added:
1 year ago
HRX 22 - Dr Matthew McKillop from ReadmyRhythm joins us to outline a new wearable heart monitoring platform to identify and diagnose cardiac arrhythmias in users.
Questions:
1. What are the clinical unmet needs that led to the creation of this technology?
2. What is ReadmyRhythm?
3. What is the data underpinning the use of this technology, and what future study is planned?
4. How can this…
View more
Author(s):
Juan Caro Codón
Added:
11 months ago
EHRA 2023 — Dr Juan Caro Codón (La Paz University Hospital, Madrid, ES) discusses the findings from the TEMPO-HCM study investigating extended ECG monitoring in hypertrophic cardiomyopathy (HCM) patients.
This was a prospective, observational, multicenter trial that included patients with a diagnosis of hypertrophic cardiomyopathy. Investigators compared the rate of clinically relevant…
View more
Author(s):
Alessio Galli
,
Francesco Ambrosini
,
Federico Lombardi
Added:
3 years ago
Since the 1960s, Holter monitoring has been a cornerstone for diagnosing suspected arrhythmias in patients of all ages.1 The most common monitoring systems allow the continuous registration of three or more leads for 24–48 hours; newer Holter monitors allow continuous electrocardiogram (ECG) registration for 2 weeks.1 Extending the time of ECG registration will increase the diagnostic yield of…
View more
Author(s):
Jonathan Behar
,
Francisco Leyva
,
Martin R Cowie
Added:
2 years ago
In this video from Arrhythmia Academy's Journal Club, Dr Jonathan Behar (Guy’s and St Thomas’ Hospital NHS Foundation Trust, UK) sits down with Prof. Francisco Leyva (Queen Elizabeth Hospital, Birmingham, UK) and Prof. Martin Cowie (King's College London and Royal Brompton Hospital, London, UK) to discuss innovations in healthcare technology. In this insightful video, they discuss the trends in…
View more
Author(s):
Michael G Fradley
Added:
1 year ago
In this video, we invited Dr Michael Fradley, Medical Director of the Thalheimer Center for Cardio-oncology at Penn Medicine, to discuss the topic of arrhythmias in cancer patients. Dr Fradley is an active cardiologist specialising in cardio-oncology and electrophysiology.
Discussion Points:
1. What are the main cancer treatments that cause this problem?
2. Are there risk factors that predispose…
View more